WESCAP Management Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $371K | Buy |
|
|||||
|
2025
Q1 | $354K | Sell |
|
|||||
|
2024
Q4 | $443K | Buy |
|
|||||
|
2024
Q3 | $463K | Buy |
|
|||||
|
2024
Q2 | $451K | Hold |
|
|||||
|
2024
Q1 | $592K | Sell |
|
|||||
|
2023
Q4 | $520K | Sell |
|
|||||
|
2023
Q3 | $512K | Sell |
|
|||||
|
2023
Q2 | $576K | Buy |
|
|||||
|
2023
Q1 | $522K | Sell |
|
|||||
|
2022
Q4 | $604K | Sell |
|
|||||
|
2022
Q3 | $561K | Sell |
|
|||||
|
2022
Q2 | $615K | Sell |
|
|||||
|
2022
Q1 | $832K | Hold |
|
|||||
|
2021
Q4 | $1.1M | Sell |
|
|||||
|
2021
Q3 | $1.32M | Sell |
|
|||||
|
2021
Q2 | $1.21M | Sell |
|
|||||
|
2021
Q1 | $1.03M | Sell |
|
|||||
|
2020
Q4 | $909K | Sell |
|
|||||
|
2020
Q3 | $905K | Sell |
|
|||||
|
2020
Q2 | $740K | Sell |
|
|||||
|
2020
Q1 | $570K | Hold |
|
|||||
|
2019
Q4 | $690K | Sell |
|
|||||
|
2019
Q3 | $621K | Sell |
|
|||||
|
2019
Q2 | $700K | Hold |
|
|||||
|
2019
Q1 | $716K | Sell |
|
|||||
|
2018
Q4 | $579K | Hold |
|
|||||
|
2018
Q3 | $688K | Sell |
|
|||||
|
2018
Q2 | $755K | Sell |
|
|||||
|
2018
Q1 | $820K | Sell |
|
|||||
|
2017
Q4 | $1.78M | Sell |
|
|||||
|
2017
Q3 | $1.78M | Sell |
|
|||||
|
2017
Q2 | $1.78M | Sell |
|
|||||
|
2017
Q1 | $1.61M | Buy |
|
|||||
|
2016
Q4 | $1.3M | Sell |
|
|||||
|
2016
Q3 | $1.45M | Sell |
|
|||||
|
2016
Q2 | $1.46M | Buy |
|